Global Perspectives on RWE Data Standards Beyond FDA Requirements As the pharmaceutical and medical device industries evolve, so too do the standards governing data utilization and assessment. In the United States, the FDA has established robust frameworks centered on data standards for Real-World Evidence (RWE), particularly under the auspices of the Clinical Data Interchange Standards Consortium (CDISC). The landscape, however, extends far beyond FDA mandates, requiring professionals in regulatory affairs, biostatistics, and health economics outcomes research (HEOR) to remain acutely aware of both international guidelines and the nuances of data management. This article provides a comprehensive tutorial on data standards…

Tools and Automation to Accelerate CDISC Conversion for RWD Assets Accelerating CDISC Conversion for Real-World Data Assets: Tools and Automation In the current environment of regulatory scrutiny and the increasing need for Real-World Evidence (RWE) in regulatory submissions, understanding and implementing robust data standards is paramount. The Clinical Data Interchange Standards Consortium (CDISC) provides vital frameworks such as the Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) to facilitate the organization and submission of clinical data. This article will guide professionals through the intricacies of accelerating CDISC conversion for RWE assets while reaping the benefits of automation, highlighting…

Governance for Data Standards Councils in RWE Programs Understanding Governance for Data Standards Councils in RWE Programs Real-World Evidence (RWE) initiatives have become increasingly significant in modern pharmaceutical and medical technology sectors. The need for robust governance frameworks is essential for the successful implementation of RWE programs, particularly concerning data standards. This article serves as a comprehensive guide for establishing effective governance for data standards councils, focusing primarily on CDISC, SDTM, ADaM, and HL7/FHIR frameworks. 1. Introduction to Data Standards in RWE Programs The rise of RWE emphasizes the importance of standardizing data collection, management, and analysis. In the context…

Mapping EHR and Claims Fields to CDISC Structures in Large Scale RWE Mapping EHR and Claims Fields to CDISC Structures in Large Scale RWE In the evolving landscape of real-world evidence (RWE), the integration of electronic health records (EHR) and claims data into clinical research is essential for generating meaningful insights. This article serves as a comprehensive regulatory guide for professionals navigating the complexities of mapping EHR and claims fields to CDISC data standards, including SDTM and ADaM datasets. As regulatory agencies like the FDA emphasize the importance of data standardization, understanding the nuances of this integration is pivotal for…

Data Standards for Real World Evidence: CDISC, SDTM, ADaM, and HL7 FHIR This comprehensive tutorial provides an in-depth exploration of the data standards essential for real-world evidence (RWE) within the pharmaceutical and medtech industries. We will focus on the Clinical Data Interchange Standards Consortium (CDISC) standards, specifically the Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM), and examine the integration of Fast Healthcare Interoperability Resources (FHIR). Professionals involved in regulatory compliance, biostatistics, health economics and outcomes research (HEOR), and data standards will find this guide valuable for aligning processes with US FDA expectations. The comparisons to regulatory frameworks…